Aeris Biosciences
PrivateLast Round
Seed
Jul 14, 2026
Total Funding Raised
$5.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aeris Biosciences operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Seed round in July 2026.
Aeris Biosciences is a biotechnology company that develops a platform of three-dimensional bioaerogels designed to inhibit bacterial colonization and guide tissue regeneration for wound repair, bone regeneration, and therapeutic delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aeris Biosciences Comparables
Compare Aeris Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GelSana Therapeutics | 81% | |
| Gel4Med | 79% | |
| Nanordica Medical | 77% |
For institutional investors. Book with your work email.
Aeris Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 14, 2026 | ||||
| Accelerator | Sep 30, 2025 | ||||
| Pre Seed | Apr 9, 2025 | ||||
| Grant | Mar 1, 2025 | ||||
| Grant | Apr 24, 2024 |
For institutional investors. Book with your work email.
Aeris Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio Third Frontier Commission | Grant |
| Bounce Innovation Hub | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 14, 2026
Raised $3M Seed round
- Sep 30, 2025
Raised $25K Accelerator round
For institutional investors. Book with your work email.
Aeris Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aeris Biosciences's valuation, stock price, and market status.
Is Aeris Biosciences a public or private company?
Aeris Biosciences is a private company.
What is the current stock price of Aeris Biosciences?
Aeris Biosciences is a private company, so its shares have no public market price. Caplight tracks Aeris Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aeris Biosciences worth (valuation)?
Valuation information for Aeris Biosciences is not publicly available.
Can I buy Aeris Biosciences stock?
Aeris Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aeris Biosciences's last funding round?
Aeris Biosciences's most recent funding round was Seed on July 14, 2026.
Who are the main investors in Aeris Biosciences?
Key investors in Aeris Biosciences include Ohio Third Frontier Commission, Bounce Innovation Hub, National Science Foundation.
Will Aeris Biosciences IPO soon?
No public IPO plans have been announced for Aeris Biosciences.
How can I track Aeris Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Aeris Biosciences's shares on secondary markets.